Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is no single, well-defined "alpha-linolenic acid receptor." The term refers collectively to the molecular targets, including nuclear hormone receptors like PPARs and LXRs, that mediate the diverse physiological actions of alpha-linolenic acid through gene regulation and cell signaling mechanisms.
Alpha-linolenic acid and its metabolites modulate gene expression by binding to nuclear hormone receptors such as PPARs and LXRs, altering cell membrane fluidity, influencing signal transduction pathways related to inflammation, and being metabolized into bioactive oxylipins via lipoxygenase (LOX), cyclooxygenase (COX), and cytochrome P450 pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-linolenic Acid Receptor.